Evidence map›Paper›PMID 30450113›Full record

ReviewFrontiers in genetics2018

Bringing Light to Transcription: The Optogenetics Repertoire.

Lorena de Mena, Patrick Rizk, Diego E Rincon-Limas

Abstract readReview
In one paragraph

Review in Frontiers in genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Review
  3. Apusomonad rhodopsins: A new family of ultraviolet to blue light-absorbing rhodopsin channels.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Genetics-Based Targeting Strategies for Precise Neuromodulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Article
  6. Article
  7. Construction and Characterization of Light-Responsive Transcriptional Systems.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. A structural decryption of cryptochromes.Frontiers in chemistry · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Bio-hybrid electronic and photonic devices.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. SystematicACS synthetic biology · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lorena de MenaDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, United States.
Patrick RizkDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, United States.
Diego E Rincon-LimasDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, United States.

Funding

Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer's diseaseR01AG059871 · NIA · UNIVERSITY OF FLORIDA · PI RINCON-LIMAS, DIEGO E · 2018 to 2022
$1.9M
Optogenetic modeling of primary and secondary CNS proteinopathies in DrosophilaR21NS088866 · NINDS · UNIVERSITY OF FLORIDA · PI RINCON-LIMAS, DIEGO E · 2014 to 2015
$413k
NIA NIH HHS R01 AG059871NINDS NIH HHS R21 NS088866
6 · The paper itself

Abstract

The ability to manipulate expression of exogenous genes in particular regions of living organisms has profoundly transformed the way we study biomolecular processes involved in both normal development and disease. Unfortunately, most of the classical inducible systems lack fine spatial and temporal accuracy, thereby limiting the study of molecular events that strongly depend on time, duration of activation, or cellular localization. By exploiting genetically engineered photo sensing proteins that respond to specific wavelengths, we can now provide acute control of numerous molecular activities with unprecedented precision. In this review, we present a comprehensive breakdown of all of the current optogenetic systems adapted to regulate gene expression in both unicellular and multicellular organisms. We focus on the advantages and disadvantages of these different tools and discuss current and future challenges in the successful translation to more complex organisms.

Indexed as

cryptochromegene expressionlightLOVoptogeneticsphytochrome BtranscriptionUVR8

Identifiers

PMID30450113
PMCPMC6224442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.